ATE348601T1 - Im munde zerfallende tablette enthaltend ein benzimidazole - Google Patents
Im munde zerfallende tablette enthaltend ein benzimidazoleInfo
- Publication number
- ATE348601T1 ATE348601T1 AT99919614T AT99919614T ATE348601T1 AT E348601 T1 ATE348601 T1 AT E348601T1 AT 99919614 T AT99919614 T AT 99919614T AT 99919614 T AT99919614 T AT 99919614T AT E348601 T1 ATE348601 T1 AT E348601T1
- Authority
- AT
- Austria
- Prior art keywords
- administered
- fine granules
- tablet
- average particle
- particle diameter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13547298 | 1998-05-18 | ||
JP21926698 | 1998-08-03 | ||
JP22215198 | 1998-08-05 | ||
JP514499 | 1999-01-12 | ||
JP1585199 | 1999-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE348601T1 true ATE348601T1 (de) | 2007-01-15 |
Family
ID=27518561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99919614T ATE348601T1 (de) | 1998-05-18 | 1999-05-17 | Im munde zerfallende tablette enthaltend ein benzimidazole |
Country Status (16)
Country | Link |
---|---|
US (5) | US6328994B1 (de) |
EP (3) | EP1121103B1 (de) |
JP (2) | JP3746167B2 (de) |
KR (2) | KR100554924B1 (de) |
CN (1) | CN1195500C (de) |
AT (1) | ATE348601T1 (de) |
AU (1) | AU3731699A (de) |
CA (2) | CA2587022A1 (de) |
CY (2) | CY1105908T1 (de) |
DE (1) | DE69934505T2 (de) |
DK (3) | DK2263660T3 (de) |
ES (2) | ES2274625T3 (de) |
HK (2) | HK1096021A1 (de) |
PT (3) | PT1121103E (de) |
TW (1) | TWI243062B (de) |
WO (1) | WO1999059544A2 (de) |
Families Citing this family (216)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
DK2263660T3 (en) | 1998-05-18 | 2018-01-02 | Takeda Pharmaceuticals Co | Orally disintegrating tablets. |
CA2581111A1 (en) * | 1998-07-28 | 2000-02-10 | Takeda Pharmaceutical Company Limited | Rapidly disintegrable solid preparation |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
CA2374760A1 (en) * | 1999-06-18 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20060034937A1 (en) * | 1999-11-23 | 2006-02-16 | Mahesh Patel | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
AU2001236055A1 (en) * | 2000-03-02 | 2001-09-12 | Basf Aktiengesellschaft | Coated granules and foaming compositions containing the same |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US20030185886A1 (en) * | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
RU2203042C2 (ru) * | 2000-11-28 | 2003-04-27 | Комиссарова Ирина Алексеевна | Фармацевтическая композиция и способ ее получения |
KR20030072555A (ko) * | 2000-12-07 | 2003-09-15 | 알타나 파마 아게 | 산 불안정성 활성 성분을 포함하는 신속 붕해 정제 |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
KR100777169B1 (ko) | 2001-01-29 | 2007-11-16 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서함유하는 의약 제제 |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
MXPA03007283A (es) * | 2001-02-15 | 2003-12-04 | Tanabe Seiyaku Co | Tabletas que se desintegran rapidamente en la cavidad oral. |
WO2002069939A2 (en) * | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
KR20030081489A (ko) * | 2001-03-06 | 2003-10-17 | 교와 핫꼬 고교 가부시끼가이샤 | 당알콜을 함유하는 분무건조 분말의 용도 |
WO2002069934A1 (fr) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Préparations se délitant rapidement dans la bouche |
WO2003000169A1 (en) | 2001-06-20 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Method of manufacturing tablet |
JP5138856B2 (ja) * | 2001-06-20 | 2013-02-06 | 武田薬品工業株式会社 | 錠剤の製造方法 |
PL367686A1 (en) * | 2001-07-16 | 2005-03-07 | Astrazeneca Ab | Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
WO2003020241A2 (en) * | 2001-09-05 | 2003-03-13 | Vectura Limited | Functional powders for oral delivery |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
JP2006282677A (ja) * | 2001-10-17 | 2006-10-19 | Takeda Chem Ind Ltd | 酸に不安定な薬物の高含量顆粒 |
CA2463690C (en) * | 2001-10-17 | 2011-08-23 | Takeda Chemical Industries, Ltd. | Granules containing acid-unstable chemical in large amount |
JP4331930B2 (ja) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
US20030190359A1 (en) * | 2001-10-29 | 2003-10-09 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
AU2002366029B2 (en) * | 2001-11-21 | 2008-01-31 | Eisai R And D Management Co., Ltd. | Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same |
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
JP4833464B2 (ja) * | 2001-11-28 | 2011-12-07 | 大正製薬株式会社 | 難溶性薬物含有固形製剤の製造方法 |
KR20040098009A (ko) * | 2002-03-06 | 2004-11-18 | 교와 핫꼬 고교 가부시끼가이샤 | 구강 내 속붕괴성 정제 |
US6572889B1 (en) * | 2002-03-07 | 2003-06-03 | Noveon Ip Holdings Corp. | Controlled release solid dosage carbamazepine formulations |
AU2003209475A1 (en) * | 2002-03-07 | 2003-09-16 | Vectura Limited | Fast melt multiparticulate formulations for oral delivery |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
US20040005362A1 (en) * | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
JP4169329B2 (ja) * | 2002-10-04 | 2008-10-22 | 村樫石灰工業株式会社 | 消石灰系塗材組成物 |
US8697094B2 (en) * | 2002-10-16 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
FR2845915B1 (fr) * | 2002-10-21 | 2006-06-23 | Negma Gild | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20040208931A1 (en) * | 2002-12-30 | 2004-10-21 | Friend David R | Fast dissolving films for oral administration of drugs |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
CA2517289A1 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition of rabeprazole and processes for their preparation |
CA2518780C (en) * | 2003-03-12 | 2014-05-13 | Takeda Pharmaceutical Company Limited | Drug composition having active ingredient adhered at high concentration to spherical core |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2531564C (en) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
FR2858556B1 (fr) * | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
EP1696889A1 (de) * | 2003-08-28 | 2006-09-06 | Ranbaxy Laboratories, Ltd. | Pharmazeutische zusammensetzungen von benzimidazol und verfahren zu ihrer herstellung |
GB0320522D0 (en) * | 2003-09-02 | 2003-10-01 | Glaxo Group Ltd | Formulation |
ATE549015T1 (de) * | 2003-10-31 | 2012-03-15 | Hexal Ag | Pharmazeutische wirkstoffhaltige formulierung mit überzug |
AU2005213472A1 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
KR100794078B1 (ko) * | 2004-03-26 | 2008-01-10 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 용출 제어 제제 및 그의 제조 방법 |
CA2561700A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
KR20050118775A (ko) * | 2004-06-15 | 2005-12-20 | 주식회사 태평양 | 당류의 재결정화 및 약물과의 가교형성을 이용한 구강내속붕해정 |
JP2008502740A (ja) * | 2004-06-15 | 2008-01-31 | テバ ファーマシューティカル インダストリーズ リミティド | ベンズイミダゾール化合物の安定医薬製剤 |
WO2006009602A2 (en) | 2004-06-16 | 2006-01-26 | Tap Pharmaceutical Products, Inc. | Multiple ppi dosage form |
EP1621187A1 (de) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung |
JP4691925B2 (ja) * | 2004-08-05 | 2011-06-01 | 田辺三菱製薬株式会社 | 圧縮成型製剤の製造方法 |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US8057820B2 (en) * | 2004-10-08 | 2011-11-15 | Mcneil-Ppc, Inc. | Enteric coated aspirin granules comingled with binder |
US8758814B2 (en) | 2004-10-08 | 2014-06-24 | Mcneil-Ppc, Inc. | Chewable enteric coated aspirin tablets |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
US20060105039A1 (en) * | 2004-10-21 | 2006-05-18 | Jin-Wang Lai | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
CN100393304C (zh) * | 2005-02-28 | 2008-06-11 | 上海艾力斯医药科技有限公司 | 一种包含酸不稳定药物的微细颗粒及其制剂 |
IS7724A (is) | 2005-03-02 | 2006-09-03 | Actavis Group | Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
US20090148519A1 (en) * | 2005-09-29 | 2009-06-11 | Yasuhiro Zaima | Pulsed-release preparation having improved disintegration properties in vivo |
CA2624179A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
WO2007046102A2 (en) | 2005-10-19 | 2007-04-26 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
CN100431526C (zh) * | 2005-11-07 | 2008-11-12 | 上海艾力斯医药科技有限公司 | 一种酸敏感型药物的快速崩解片剂 |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
JP2009519334A (ja) * | 2005-12-20 | 2009-05-14 | テバ ファーマシューティカル インダストリーズ リミティド | ランソプラゾール経口崩壊錠剤 |
CA2633825A1 (en) * | 2005-12-20 | 2007-07-05 | Teva Pharmaceutical Industries Ltd. | Lansoprazole orally disintegrating tablets |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
EP1813275A1 (de) * | 2005-12-20 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | In der Mundhöle zerfallende Lansoprazol-Tabletten |
ZA200805706B (en) * | 2005-12-28 | 2010-02-24 | Takeda Pharmaceutical | Controlled release solid preparation |
BRPI0620787A2 (pt) | 2005-12-28 | 2011-11-22 | Takeda Pharmaceutical | preparação sólida |
WO2007074856A1 (ja) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | 口腔内崩壊性固形製剤の製造法 |
JP3884056B1 (ja) * | 2006-01-27 | 2007-02-21 | 秋山錠剤株式会社 | 口腔内速崩錠の製造方法 |
DE602007010254D1 (de) * | 2006-03-16 | 2010-12-16 | Novartis Ag | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack |
WO2007113856A2 (en) * | 2006-03-31 | 2007-10-11 | Rubicon Research Private Limited | Directly compressible composite for orally disintegrating tablets |
WO2007122478A2 (en) * | 2006-04-20 | 2007-11-01 | Themis Laboratories Private Limited | Multiple unit compositions |
EP2026768B1 (de) * | 2006-06-01 | 2018-02-28 | Dexcel Pharma Technologies Ltd. | Pharmazeutische formulierung auf mehreren einheiten |
JP5141115B2 (ja) * | 2006-07-11 | 2013-02-13 | 大正製薬株式会社 | 不快味を呈する薬物含有製剤粒子 |
EP2042162B1 (de) | 2006-07-19 | 2017-10-04 | Asahi Kasei Kabushiki Kaisha | Verfahren zur herstellung von sphärischem elementarem granulat mit einem leicht wasserlöslichen arzneimittel |
EP2050438B1 (de) * | 2006-07-26 | 2016-10-19 | Asahi Kasei Kabushiki Kaisha | Kugelförmiges grobes granulat und herstellungsverfahren dafür |
US20080031944A1 (en) * | 2006-08-04 | 2008-02-07 | Cima Labs Inc. | Stabilization of lorazepam |
EP2058010B1 (de) * | 2006-08-10 | 2012-05-02 | Takeda Pharmaceutical Company Limited | Pharmazeutische zusammensetzung |
EP2062599A4 (de) * | 2006-09-14 | 2013-03-27 | Astellas Pharma Inc | Oral zerfallende tablette und verfahren zu ihrer herstellung |
GB2459393B (en) | 2006-10-05 | 2010-09-08 | Santarus Inc | Novel capsule formulation for the proton pump inhibitor omeprazole |
WO2008062320A2 (en) * | 2006-10-06 | 2008-05-29 | Eisai R&D Management Co., Ltd | Extended release formulations of a proton pump inhibitor |
MX2009004475A (es) | 2006-10-27 | 2009-08-12 | Univ Missouri | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. |
US8668703B2 (en) * | 2006-12-01 | 2014-03-11 | Wake Forest University Health Sciences | Medical devices incorporating collagen inhibitors |
US8362088B2 (en) * | 2006-12-14 | 2013-01-29 | Warnock W Matthew | Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient |
EP2101738A2 (de) * | 2006-12-21 | 2009-09-23 | Mallinckrodt Inc. | Zusammensetzung und verfahren zur herstellung von im mund zerfallenden tabletten |
EP2098250B1 (de) * | 2006-12-28 | 2016-09-28 | Takeda Pharmaceutical Company Limited | Oral zerfallende feste zubereitung |
JP3967767B1 (ja) * | 2007-02-08 | 2007-08-29 | 秋山錠剤株式会社 | 口腔内速崩錠の製造方法 |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
TWI405574B (zh) * | 2007-06-21 | 2013-08-21 | Otsuka Pharma Co Ltd | 藥學固體製劑及其製造方法 |
KR101436516B1 (ko) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 |
EP2471515A3 (de) | 2007-09-14 | 2012-12-26 | Wockhardt Limited | Rhein- oder Diacereinzusammensetzungen |
EP2044929A1 (de) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Schnell lösliche Tabletten für orale Anwendung |
EP2044943A1 (de) * | 2007-10-04 | 2009-04-08 | Solvay Pharmaceuticals, Inc. | Pharmazeutische Zusammensetzungen mit veresterten Östrogenen und Methyltestosteron und Verwendungsverfahren dafür |
EP2044932A1 (de) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanische Schutzschicht für feste Darreichungsformen |
KR20170097787A (ko) | 2007-10-12 | 2017-08-28 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 음식 섭취와 관계없이 위장 장애를 치료하는 방법 |
CN101842085B (zh) | 2007-10-31 | 2013-01-30 | 麦克内尔-Ppc股份有限公司 | 口腔崩解剂型 |
US8268356B2 (en) | 2007-11-16 | 2012-09-18 | Asahi Kasei Chemicals Corporation | Aqueous film coating solution, film coated granule and tablet using the same |
JPWO2009069280A1 (ja) * | 2007-11-27 | 2011-04-07 | 大原薬品工業株式会社 | 造粒物の製造法 |
CN105496978A (zh) * | 2007-12-21 | 2016-04-20 | 阿代尔制药股份有限公司 | 替马西泮的口腔崩解片组合物 |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
TWI441658B (zh) | 2008-03-11 | 2014-06-21 | Takeda Pharmaceutical | 口腔崩解固體製劑 |
JP5399749B2 (ja) * | 2008-03-27 | 2014-01-29 | 沢井製薬株式会社 | プロトンポンプ阻害剤を含有する被覆微粒子 |
JP5296456B2 (ja) * | 2008-08-26 | 2013-09-25 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
US8900634B2 (en) | 2008-11-03 | 2014-12-02 | Nal Pharmaceuticals, Ltd. | Diethylstilbestrol dosage form and methods of treatment using thereof |
US8715715B2 (en) | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
EP2362725B1 (de) | 2008-11-04 | 2015-01-07 | Vymedic, Llc | Antivirale Ergänzungsformulierung |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
KR101565621B1 (ko) * | 2009-01-26 | 2015-11-03 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 저치환도 히드록시프로필셀룰로오스 수분산액을 이용한 습식 조립 타정법 |
JP5503192B2 (ja) * | 2009-06-03 | 2014-05-28 | 大原薬品工業株式会社 | 生理活性物質含有粒子の製造方法 |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
US8343533B2 (en) | 2009-09-24 | 2013-01-01 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
EP2486918A4 (de) | 2009-10-09 | 2014-02-26 | Yungjin Pharmaceutical Co Ltd | Pharmazeutische zusammensetzung mit sowohl sofortiger als auch verzögerter freisetzung |
EP2319504A1 (de) * | 2009-11-07 | 2011-05-11 | Laboratorios Del. Dr. Esteve, S.A. | Feste pharmazeutische Dosierform |
CN102958515A (zh) | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2519229A2 (de) | 2009-12-29 | 2012-11-07 | Novartis AG | Neue pharmazeutische darreichungsform zur behandlung von magensäurebedingten erkrankungen |
WO2011085181A1 (en) * | 2010-01-08 | 2011-07-14 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
WO2011111027A2 (en) | 2010-03-11 | 2011-09-15 | Dexcel Pharma Technologies Ltd. | Oral dispersible delayed release tablet formulation |
US20130202688A1 (en) | 2010-05-04 | 2013-08-08 | Sunilendu Bhushan Roy | Delayed release oral disintegrating pharmaceutical compositions of lansoprazole |
US20110300216A1 (en) * | 2010-06-03 | 2011-12-08 | First Eric R | Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives |
NZ605562A (en) * | 2010-07-09 | 2013-11-29 | Teijin Pharma Ltd | Deuterated benzylbenzene derivatives and methods of use |
MX2013000284A (es) * | 2010-07-09 | 2013-03-18 | Teijin Pharma Ltd | Tableta de desintegracion intraoral. |
JP2012051832A (ja) * | 2010-08-31 | 2012-03-15 | Fancl Corp | 顆粒組成物及びそれを含有する食品又は医薬品 |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
JP2011046750A (ja) * | 2010-12-09 | 2011-03-10 | Mitsubishi Tanabe Pharma Corp | 口腔内速崩壊性錠 |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
EP2468263A1 (de) * | 2010-12-23 | 2012-06-27 | Laboratorios Del. Dr. Esteve, S.A. | Komprimierte feste Darreichungsformen |
SG10201602311XA (en) | 2010-12-27 | 2016-04-28 | Takeda Pharmaceutical | Orally disintegrating tablet |
US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
CA2824430A1 (en) | 2011-01-17 | 2012-07-26 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
JP5725884B2 (ja) * | 2011-01-27 | 2015-05-27 | 理研ビタミン株式会社 | 経口用製剤 |
US8568776B2 (en) * | 2011-02-11 | 2013-10-29 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
JP5835849B2 (ja) | 2011-03-17 | 2015-12-24 | 協和化学工業株式会社 | 圧縮成形物およびその製造方法 |
WO2012169614A1 (ja) * | 2011-06-10 | 2012-12-13 | ニプロ株式会社 | 口腔内崩壊錠の製造方法 |
MY186477A (en) * | 2011-11-30 | 2021-07-22 | Takeda Pharmaceuticals Co | Dry coated tablet |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
EP2857006A4 (de) | 2012-06-05 | 2015-12-30 | Takeda Pharmaceutical | Trockenbeschichtete tablette |
CN102805737A (zh) * | 2012-09-03 | 2012-12-05 | 海南中化联合制药工业股份有限公司 | 一种兰索拉唑肠溶口崩片及其制备方法 |
RU2015132902A (ru) * | 2013-01-07 | 2017-02-09 | Сам-А Фарм. Ко., Лтд. | Новый быстрорастворимый состав гранул с улучшенной растворимостью |
US9850512B2 (en) | 2013-03-15 | 2017-12-26 | The Research Foundation For The State University Of New York | Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield |
JP6258920B2 (ja) * | 2013-03-27 | 2018-01-10 | Meiji Seikaファルマ株式会社 | 口腔内崩壊性フィルムコーティング錠 |
WO2014175916A1 (en) | 2013-04-23 | 2014-10-30 | Zx Pharma, Llc | Enteric coated multiparticulate composition with proteinaceous subcoat |
JP5758552B2 (ja) | 2013-05-08 | 2015-08-05 | 全星薬品工業株式会社 | 機能性高分子皮膜で被覆された高含量薬物粒子およびそれを含む錠剤ならびにそれらの製造方法 |
WO2014189034A1 (ja) | 2013-05-21 | 2014-11-27 | 武田薬品工業株式会社 | 口腔内崩壊錠 |
JP5714652B2 (ja) * | 2013-06-13 | 2015-05-07 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
EP3091966B1 (de) | 2014-01-10 | 2019-07-31 | Johnson & Johnson Consumer Inc. | Verfahren zur herstellung einer tablette mit funkfrequenz und verlustbehafteten beschichteten partikeln |
WO2015119289A1 (ja) * | 2014-02-10 | 2015-08-13 | 富士フイルム株式会社 | 口腔内崩壊錠 |
US9951363B2 (en) | 2014-03-14 | 2018-04-24 | The Research Foundation for the State University of New York College of Environmental Science and Forestry | Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects |
WO2015153984A2 (en) | 2014-04-04 | 2015-10-08 | Pharmaquest International Center, LLC | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US10105322B2 (en) * | 2014-10-08 | 2018-10-23 | Synthetic Biologics, Inc. | Beta-lactamase formulations and uses thereof |
GB201420306D0 (en) * | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
JP6670113B2 (ja) * | 2015-01-20 | 2020-03-18 | 日本ケミファ株式会社 | ロスバスタチンカルシウム製剤及びレーザー照射によるフィルムコーティング錠の印字方法 |
US9744135B2 (en) | 2015-02-27 | 2017-08-29 | Deseret Laboratories, Inc. | Fast disintegrating compositions and tablets thereof |
JP5978335B2 (ja) * | 2015-03-11 | 2016-08-24 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
WO2016154313A1 (en) * | 2015-03-24 | 2016-09-29 | Zywie, Llc | High drug loading liquid oral pharmaceutical compositions |
BR112017020790A2 (pt) * | 2015-03-31 | 2018-06-26 | Laboratorios Bagó S.A. | procedimento para preparação de pelotas com revestimento entérico contendo um inibidor de bomba de prótons e composições farmacêuticas em multipartículas que contêm as mesmas |
EP3288556A4 (de) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Oral zerfallende zusammensetzungen |
JP6469234B2 (ja) * | 2015-09-04 | 2019-02-13 | 株式会社ダイセル | 超速崩壊錠剤及びその製造方法 |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP6151413B2 (ja) * | 2016-07-25 | 2017-06-21 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
EP3544614A4 (de) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | Orale testosteron-undecanoat-therapie |
JP6866136B2 (ja) * | 2016-11-30 | 2021-04-28 | 共和薬品工業株式会社 | デュロキセチン塩酸塩を含む口腔内崩壊錠 |
JP7064683B2 (ja) * | 2017-01-27 | 2022-05-11 | 日本ケミファ株式会社 | 腸溶層破損防止用組成物 |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
JP2017141299A (ja) * | 2017-05-24 | 2017-08-17 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
MX2019015120A (es) | 2017-06-12 | 2022-07-14 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos. |
EP3673901A4 (de) | 2017-08-21 | 2021-05-19 | Nipro Corporation | Teilchen einer pharmazeutischen zusammensetzung, oral zerfallendes präparat damit und verfahren zur herstellung von teilchen einer pharmazeutischen zusammensetzung |
CN108576205B (zh) * | 2018-03-22 | 2022-01-04 | 湖北省农业科学院农产品加工与核农技术研究所 | 一种草莓联合干燥的处理方法 |
JP2018168185A (ja) * | 2018-07-05 | 2018-11-01 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
DE102019201445A1 (de) | 2019-02-05 | 2020-08-06 | Kniele Gmbh | Schräglagenmischer |
US11779541B2 (en) | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
JP2019203031A (ja) * | 2019-09-06 | 2019-11-28 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
JP7404828B2 (ja) | 2019-11-29 | 2023-12-26 | ニプロ株式会社 | 経口医薬製剤およびその製造方法 |
JPWO2021153525A1 (de) * | 2020-01-27 | 2021-08-05 | ||
EP4142699A1 (de) | 2020-04-30 | 2023-03-08 | Nanocopoeia LLC | Im mund zerfallende tablette mit amorpher fester dispersion von nilotinib |
KR102553713B1 (ko) * | 2022-11-18 | 2023-07-10 | 고덕상 | 미네랄 촉매제를 이용한 양식어류사료 제조방법 |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
JPS5163927A (en) | 1974-11-28 | 1976-06-02 | Shinetsu Chemical Co | Ketsugoseiryokonajozaihokaizaino seizohoho |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
JPS5411226A (en) | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS5614098A (en) | 1979-07-13 | 1981-02-10 | Takeda Chem Ind Ltd | Externally lubricating tablet making machine |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
ZA828136B (en) | 1981-11-05 | 1983-09-28 | Byk Gulden Lomberg Chem Fab | Substituted benzimidazoles,a process for their preparation,their use,and medicaments containing them |
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
SE8404808L (sv) * | 1983-10-03 | 1985-04-04 | Avner Rotman | Mikrokapslat lekemedel i sot matris |
IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IT1177384B (it) * | 1984-12-12 | 1987-08-26 | Boeehringer Biochemia Robin Sp | Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione |
JPH072761B2 (ja) | 1985-03-20 | 1995-01-18 | 不二パウダル株式会社 | 微結晶セルロ−ス球形顆粒及びその製造法 |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
JPS62111980A (ja) | 1985-11-08 | 1987-05-22 | Otsuka Pharmaceut Co Ltd | 1h−ベンズイミダゾ−ル誘導体 |
GB8530365D0 (en) * | 1985-12-10 | 1986-01-22 | Univ Bath | Manufacture of moulded products |
CA1327010C (en) | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
JPS62277322A (ja) | 1986-02-13 | 1987-12-02 | Takeda Chem Ind Ltd | 安定化された腸溶性抗潰瘍固形組成物 |
US5433959A (en) * | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
JPH0674272B2 (ja) | 1986-11-13 | 1994-09-21 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
JPH0832625B2 (ja) | 1987-01-29 | 1996-03-29 | 武田薬品工業株式会社 | 有核顆粒およびその製造法 |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JP2718945B2 (ja) | 1987-06-17 | 1998-02-25 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
US5030447A (en) | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
JPH0720858B2 (ja) | 1988-04-19 | 1995-03-08 | 三菱化学株式会社 | 被覆固形薬剤 |
JPH0723304B2 (ja) | 1988-04-19 | 1995-03-15 | 三菱化学株式会社 | 薬剤成分固定化組成物 |
US4910023A (en) | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
NZ230763A (en) * | 1988-09-27 | 1991-10-25 | Takeda Chemical Industries Ltd | Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient |
GB8824392D0 (en) | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
US4936074A (en) * | 1988-11-17 | 1990-06-26 | D. M. Graham Laboratories, Inc. | Process for preparing solid encapsulated medicament |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
DE69111287T2 (de) | 1990-04-18 | 1995-12-21 | Asahi Chemical Ind | Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung. |
JPH0466538A (ja) | 1990-07-04 | 1992-03-02 | Suntory Ltd | 抗潰瘍剤 |
JP3163382B2 (ja) | 1990-10-17 | 2001-05-08 | 武田薬品工業株式会社 | ピリジン誘導体およびその製造法 |
US5316772A (en) | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
JP2820829B2 (ja) | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
JPH05117268A (ja) | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
DE69331839T2 (de) | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries Ltd | Schnellösliche Tablette und ihre Herstellung |
JPH05310558A (ja) | 1992-05-07 | 1993-11-22 | Lion Corp | 固形製剤組成物 |
JP3059004B2 (ja) | 1992-09-18 | 2000-07-04 | ダイセル化学工業株式会社 | アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法 |
JPH06305962A (ja) | 1993-04-21 | 1994-11-01 | Taisho Pharmaceut Co Ltd | アトピー性皮膚炎治療剤 |
JP3502951B2 (ja) | 1993-07-06 | 2004-03-02 | 大正製薬株式会社 | 高脂血症治療剤 |
IL110376A (en) | 1993-08-02 | 1998-08-16 | Bristol Myers Squibb Co | Pharmaceutical preparations containing iftroban and methods for their preparation |
US5935600A (en) * | 1993-09-10 | 1999-08-10 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing comestible unit and product therefrom |
US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
PT723777E (pt) | 1993-10-12 | 2002-11-29 | Mitsubishi Pharma Corp | Comprimido contendo granulos entericos |
JP2681601B2 (ja) | 1993-11-01 | 1997-11-26 | 協和醗酵工業株式会社 | 外部滑沢式打錠機 |
US5549911A (en) | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
RU2147227C1 (ru) | 1994-01-31 | 2000-04-10 | Яманоути Фармасьютикал Ко., Лтд. | Растворяющиеся внутри ротовой полости изделия, сформованные прессованием, и способ их производства |
US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
IL112779A (en) * | 1994-03-01 | 1999-11-30 | Gergely Gerhard | Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation |
PL180395B1 (pl) * | 1994-07-08 | 2001-01-31 | Astra Ab | Doustna farmaceutyczna tabletkowana postac dawkowania oraz sposób wytwarzania doustnej farmaceutycznej tabletkowanej postaci dawkowania PL PL PL PL PL PL PL PL PL PL |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
JPH0827033A (ja) | 1994-07-14 | 1996-01-30 | Nikken Chem Co Ltd | エリスリトール含有固形剤 |
SE9500422D0 (sv) | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
JP2919771B2 (ja) | 1995-04-17 | 1999-07-19 | 佐藤製薬株式会社 | 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤 |
US5656284A (en) * | 1995-04-24 | 1997-08-12 | Balkin; Michael S. | Oral transmucosal delivery tablet and method of making it |
SE9501881D0 (sv) | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
JPH08310969A (ja) | 1995-05-22 | 1996-11-26 | Lion Corp | 固形薬品組成物及びその製造方法 |
US5658583A (en) | 1995-07-28 | 1997-08-19 | Zhang; Jie | Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
JPH0948726A (ja) | 1995-08-07 | 1997-02-18 | Tanabe Seiyaku Co Ltd | 口腔内速崩壊性製剤およびその製法 |
JPH0971523A (ja) | 1995-09-07 | 1997-03-18 | Riyuukakusan:Kk | 口腔内で崩壊性の速い錠剤 |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
NZ330864A (en) | 1996-02-29 | 2001-07-27 | Fujisawa Pharmaceutical Co | Beta-lactam antibiotic-containing tablet including a disintegrant and a binder |
EP0799616A1 (de) | 1996-04-01 | 1997-10-08 | Takeda Chemical Industries, Ltd. | Orale Zubereitung enthaltend ein Fumagillolderivat |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US20010014340A1 (en) | 1996-06-14 | 2001-08-16 | Motohiro Ohta | Intrabuccally rapidly disintegrating tablet |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
EP1380308B1 (de) | 1996-07-12 | 2008-07-09 | Daiichi Pharmaceutical Co., Ltd. | Schnell zerfallende, druckgeformte Materialien sowie Prozess zu deren Herstellung |
US5958453A (en) | 1996-10-31 | 1999-09-28 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility |
KR100343062B1 (ko) | 1996-11-15 | 2002-07-02 | 에가시라 구니오 | 정제 조성물 |
ATE421318T1 (de) * | 1997-02-20 | 2009-02-15 | Massachusetts Inst Technology | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
US5968453A (en) * | 1997-07-17 | 1999-10-19 | Carolina Liquid Chemistries Corporation | Reagent cartridge |
US5869098A (en) * | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
DK2263660T3 (en) | 1998-05-18 | 2018-01-02 | Takeda Pharmaceuticals Co | Orally disintegrating tablets. |
CA2581111A1 (en) | 1998-07-28 | 2000-02-10 | Takeda Pharmaceutical Company Limited | Rapidly disintegrable solid preparation |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
JP4066538B2 (ja) | 1998-11-06 | 2008-03-26 | 株式会社大林組 | 廃棄物処分場 |
JP3452862B2 (ja) | 2000-03-21 | 2003-10-06 | 株式会社野島角清製作所 | 雨樋受具 |
-
1999
- 1999-05-17 DK DK10177471.9T patent/DK2263660T3/en active
- 1999-05-17 AT AT99919614T patent/ATE348601T1/de active
- 1999-05-17 DE DE69934505T patent/DE69934505T2/de not_active Expired - Lifetime
- 1999-05-17 AU AU37316/99A patent/AU3731699A/en not_active Abandoned
- 1999-05-17 CA CA002587022A patent/CA2587022A1/en not_active Abandoned
- 1999-05-17 DK DK99919614T patent/DK1121103T3/da active
- 1999-05-17 JP JP13517799A patent/JP3746167B2/ja not_active Expired - Fee Related
- 1999-05-17 CA CA002323680A patent/CA2323680C/en not_active Expired - Lifetime
- 1999-05-17 PT PT99919614T patent/PT1121103E/pt unknown
- 1999-05-17 PT PT101774719T patent/PT2263660T/pt unknown
- 1999-05-17 ES ES99919614T patent/ES2274625T3/es not_active Expired - Lifetime
- 1999-05-17 WO PCT/JP1999/002548 patent/WO1999059544A2/en active IP Right Grant
- 1999-05-17 US US09/355,781 patent/US6328994B1/en not_active Expired - Lifetime
- 1999-05-17 KR KR1020007011763A patent/KR100554924B1/ko not_active IP Right Cessation
- 1999-05-17 CN CNB998055115A patent/CN1195500C/zh not_active Expired - Lifetime
- 1999-05-17 EP EP99919614A patent/EP1121103B1/de not_active Revoked
- 1999-05-17 EP EP10177471.9A patent/EP2263660B1/de not_active Expired - Lifetime
- 1999-05-17 ES ES06076634.2T patent/ES2559766T3/es not_active Expired - Lifetime
- 1999-05-17 KR KR1020047021546A patent/KR101032289B1/ko not_active IP Right Cessation
- 1999-05-17 DK DK06076634.2T patent/DK1736144T3/en active
- 1999-05-17 EP EP06076634.2A patent/EP1736144B1/de not_active Expired - Lifetime
- 1999-05-17 PT PT60766342T patent/PT1736144E/pt unknown
- 1999-05-18 TW TW088108021A patent/TWI243062B/zh not_active IP Right Cessation
-
2000
- 2000-05-12 JP JP2000139587A patent/JP4454791B2/ja not_active Expired - Lifetime
-
2001
- 2001-09-22 HK HK07102071.1A patent/HK1096021A1/zh not_active IP Right Cessation
- 2001-09-22 HK HK01106717A patent/HK1036401A1/xx not_active IP Right Cessation
- 2001-10-30 US US10/017,755 patent/US7431942B2/en not_active Expired - Fee Related
-
2007
- 2007-01-08 CY CY20071100020T patent/CY1105908T1/el unknown
-
2008
- 2008-05-07 US US12/151,572 patent/US7875292B2/en not_active Expired - Fee Related
-
2010
- 2010-12-14 US US12/967,858 patent/US20110081412A1/en not_active Abandoned
-
2014
- 2014-05-27 US US14/287,740 patent/US9901546B2/en not_active Expired - Fee Related
-
2016
- 2016-01-28 CY CY20161100080T patent/CY1119153T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE348601T1 (de) | Im munde zerfallende tablette enthaltend ein benzimidazole | |
KR100780156B1 (ko) | 맛 차폐용 코팅 조성물 | |
EP1276470B1 (de) | Beschichtungszusammensetzung zur geschmacksmaskierung | |
HUP0103388A2 (hu) | Orális, folyékony mukoadhezív készítmények | |
CA2238271A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
ZA200205512B (en) | Novel substituted benzimidazole dosage forms and methods of using same. | |
DE59702733D1 (de) | Gut schluckbare orale arzneiform | |
ATE345782T1 (de) | Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen | |
ZA963854B (en) | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids. | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
JP3170855B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
HUP0103685A2 (hu) | Orális, folyékony mukoadhezív készítmények | |
DK2051693T3 (da) | Letsynkelige farmaceutiske sammensætninger, der ikke forårsager en ubehagelig følelse i munden, og som omfatter partikler med et virksomt stof | |
WO2004032843A3 (en) | Mucoadhesive tetracycline formulations | |
UY26176A1 (es) | Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas. | |
AU2001295839A1 (en) | Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa | |
PT95867A (pt) | Processo para a preparacao de uma composicao de libertacao retardada compreendendo um copolimero de lactide e glicolide, para tratamento de doencas periodonticas | |
NO964775L (no) | Fast farmasöytisk adenosinholdig preparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1121103 Country of ref document: EP |